Application of ERAS Protocol in Emergency Surgery (ERAS in CDU)

July 27, 2022 updated by: University of Milano Bicocca
This study defines a standardized protocol inspired to the ERAS philosophy for the peri-operative treatment of patients undergoing emergency abdominal surgery. Primary endpoint is the feasibility of the application of the standardized protocol; secondary endpoint is the safety

Study Overview

Study Type

Observational

Enrollment (Actual)

589

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lodi, Italy
        • ASST Lodi
      • Pisa, Italy
        • Azienda ospedaliero-universitaria Pisana,Ospedale Cisanello
      • Pistoia, Italy
        • Ospedale San Jacopo
      • Roma, Italy
        • Policlinico Gemelli
      • Trieste, Italy
        • Ospedale di Cattinara
    • LC
      • Lecco, LC, Italy
        • Ospedale Manzoni
    • MB
      • Monza, MB, Italy, 20900
        • ASST Monza
    • Mi
      • Milano, Mi, Italy
        • Ospedale San Raffaele

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All patients undergoing emergency surgery for abdominal sepsis or occlusion and treated with bowel resection with or without anastomosis, intestinal bypass or adhesiolysis.

Description

Inclusion Criteria:

  • patients undergoing emergency abdominal surgery for abdominal sepsis or occlusion and treated with bowel resection with or without anastomosis, intestinal bypass or adhesiolysis.

Exclusion Criteria:

  • age <18
  • emergency surgery for post-operative complications of post diagnostic procedures

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Study population
All patients undergoing emergency abdominal surgery for infection or occlusion and treated with bowel resection with or without anastomosis; intestinal bypass or adhesiolysis
Application of a standardized ERAS protocol for the perioperative perioperative management of patients undergoing emergency surgery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility: % of application of post-operative ERAS items
Time Frame: 30 days
Compliance to the standardize protocol for each item
30 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Safety: complications rate within 30 days
Time Frame: 30 days
Complication rate and mortality
30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Marco Braga, MD, University of Milano Bicocca

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 3, 2020

Primary Completion (Actual)

March 30, 2022

Study Completion (Actual)

June 30, 2022

Study Registration Dates

First Submitted

November 23, 2020

First Submitted That Met QC Criteria

November 23, 2020

First Posted (Actual)

December 1, 2020

Study Record Updates

Last Update Posted (Actual)

July 28, 2022

Last Update Submitted That Met QC Criteria

July 27, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ERAS in CDU

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Enhanced Recovery After Surgery

Clinical Trials on Application of ERAS protocol

3
Subscribe